,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,22.1,Death,17015276,
0,22.1,Pyrexia,17015301,3
1,22.1,Pneumonitis,17015301,1
2,22.1,Diabetes mellitus,17015301,2
3,22.1,Dyspnoea at rest,17015301,3
0,22.1,Intentional product use issue,17015325,6
1,22.1,Autoimmune arthritis,17015325,6
0,22.1,Rash,17015336,
0,22.1,Circulatory collapse,17015351,1
1,22.1,Encephalopathy,17015351,1
2,22.1,Metabolic acidosis,17015351,1
3,22.1,Vomiting,17015351,1
4,22.1,Renal failure,17015351,1
5,22.1,Hyperammonaemia,17015351,1
6,22.1,Pneumonia aspiration,17015351,1
7,22.1,Diarrhoea,17015351,1
0,22.1,Pneumonitis,17015377,6
1,22.1,Rash,17015377,6
2,22.1,Immune system disorder,17015377,6
3,22.1,Death,17015377,5
4,22.1,Fatigue,17015377,6
5,22.1,Colitis,17015377,6
6,22.1,Transaminases increased,17015377,6
7,22.1,Acute kidney injury,17015377,6
0,22.1,Bicytopenia,17015417,2
0,22.1,Encephalitis viral,17015418,1
1,22.1,Opsoclonus myoclonus,17015418,1
2,22.1,Hypogammaglobulinaemia,17015418,6
0,22.1,Disease progression,17015438,
0,22.1,Neoplasm progression,17015520,6
1,22.1,Neuropathy peripheral,17015520,6
0,22.1,Neoplasm progression,17015547,6
1,22.1,Neuropathy peripheral,17015547,6
0,22.1,Neuropathy peripheral,17015551,6
1,22.1,Neoplasm progression,17015551,6
0,22.1,Neuropathy peripheral,17015556,6
1,22.1,Neoplasm progression,17015556,6
0,22.1,Neoplasm progression,17015559,6
1,22.1,Pancreatitis acute,17015559,6
2,22.1,Diabetic ketoacidosis,17015559,6
3,22.1,Toxicity to various agents,17015559,6
0,22.1,Neuropathy peripheral,17015563,6
1,22.1,Proteinuria,17015563,6
2,22.1,Neoplasm progression,17015563,6
0,22.1,Toxicity to various agents,17015564,6
1,22.1,Neoplasm progression,17015564,6
2,22.1,Diabetic ketoacidosis,17015564,6
3,22.1,Pancreatitis acute,17015564,6
0,22.1,Gilbert^s syndrome,17015566,6
0,22.1,Neoplasm progression,17015586,6
1,22.1,Neutropenia,17015586,6
2,22.1,Epistaxis,17015586,6
3,22.1,Rectal haemorrhage,17015586,6
0,22.1,Spinal fracture,17015591,3
1,22.1,Fall,17015591,6
0,22.1,Pulmonary embolism,17015593,6
1,22.1,Embolism venous,17015593,6
0,22.1,Neoplasm progression,17015594,6
1,22.1,Neurotoxicity,17015594,6
0,22.1,Transaminases increased,17015596,1
1,22.1,Condition aggravated,17015596,3
2,22.1,Gamma-glutamyltransferase increased,17015596,3
0,22.1,Bacterial sepsis,17015602,5
0,22.1,Headache,17015606,3
1,22.1,Erectile dysfunction,17015606,6
2,22.1,Insurance issue,17015606,6
3,22.1,Asthenia,17015606,6
4,22.1,Weight bearing difficulty,17015606,6
5,22.1,Pain in extremity,17015606,6
6,22.1,Myalgia,17015606,6
7,22.1,Liver disorder,17015606,6
8,22.1,Fatigue,17015606,6
9,22.1,Product dose omission,17015606,6
10,22.1,Visual impairment,17015606,2
11,22.1,Hepatic enzyme increased,17015606,6
0,22.1,Pancreatic disorder,17015635,1
1,22.1,Gallbladder disorder,17015635,6
2,22.1,Liver disorder,17015635,6
3,22.1,Cholelithiasis,17015635,1
4,22.1,Tumour marker increased,17015635,6
0,22.1,Death,17015644,5
0,22.1,Arthritis,17015651,3
1,22.1,Cancer pain,17015651,6
2,22.1,Mobility decreased,17015651,3
3,22.1,Neuropathy peripheral,17015651,1
4,22.1,Neoplasm progression,17015651,3
5,22.1,Bone pain,17015651,3
6,22.1,Arthropathy,17015651,3
7,22.1,Sciatica,17015651,3
8,22.1,Arthralgia,17015651,3
0,22.1,Liver disorder,17015686,6
0,22.1,Cellulitis,17015727,1
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,17015728,6
1,22.1,Neuropathy peripheral,17015728,6
2,22.1,Mucosal disorder,17015728,6
3,22.1,Bone marrow failure,17015728,6
4,22.1,Gastrointestinal disorder,17015728,6
0,22.1,Constipation,17015743,3
1,22.1,Diarrhoea,17015743,3
2,22.1,Vomiting,17015743,6
3,22.1,Rash,17015743,6
4,22.1,Gastrointestinal inflammation,17015743,1
5,22.1,Decreased appetite,17015743,6
6,22.1,Stomatitis,17015743,3
7,22.1,Acne pustular,17015743,3
8,22.1,Pain,17015743,3
9,22.1,Nausea,17015743,6
0,22.1,Neutropenia,17015755,6
0,22.1,Bone marrow failure,17015781,1
0,22.1,Decreased appetite,17015800,1
1,22.1,Off label use,17015800,6
2,22.1,Hyperpyrexia,17015800,1
3,22.1,Ocular hyperaemia,17015800,1
4,22.1,Mouth ulceration,17015800,1
5,22.1,Eye swelling,17015800,1
6,22.1,Rash,17015800,1
0,22.1,Pain,17015807,6
1,22.1,Malignant neoplasm progression,17015807,5
2,22.1,Off label use,17015807,6
3,22.1,General physical health deterioration,17015807,6
0,22.1,Death,17015819,5
0,22.1,Palmar-plantar erythrodysaesthesia syndrome,17015820,3
1,22.1,Cancer pain,17015820,6
2,22.1,Nausea,17015820,6
0,22.1,Pneumonia,17015827,5
0,22.1,Prostate cancer metastatic,17015834,5
0,22.1,Urinary tract infection,17015838,6
1,22.1,Prostate cancer,17015838,6
2,22.1,Drug ineffective,17015838,6
0,22.1,Subdural haematoma,17015876,5
0,22.1,Cardiac failure congestive,17015926,2
1,22.1,Malignant neoplasm progression,17015926,6
2,22.1,Hyponatraemia,17015926,4
0,22.1,Death,17015961,5
0,22.1,Death,17015969,5
0,22.1,Dupuytren^s contracture,17016008,2
0,22.1,Pneumonia,17016021,3
0,22.1,Liver disorder,17016028,
0,22.1,Blood test abnormal,17016052,2
1,22.1,Pyrexia,17016052,1
2,22.1,Nausea,17016052,1
3,22.1,Asthenia,17016052,2
4,22.1,Hepatic calcification,17016052,1
5,22.1,Inappropriate schedule of product administration,17016052,6
6,22.1,Blood bilirubin increased,17016052,2
7,22.1,Pyrexia,17016052,1
8,22.1,Jaundice,17016052,1
9,22.1,Cholecystitis,17016052,6
10,22.1,Vomiting,17016052,1
0,22.1,Alopecia,17016074,3
1,22.1,Madarosis,17016074,3
0,22.1,Thrombocytopenia,17016090,6
1,22.1,Hypercholesterolaemia,17016090,6
2,22.1,Leukopenia,17016090,6
0,22.1,Death,17016098,5
1,22.1,Neutropenia,17016098,6
2,22.1,Dyspnoea,17016098,6
3,22.1,Neoplasm progression,17016098,6
0,22.1,Alopecia,17016099,3
1,22.1,Hair colour changes,17016099,3
2,22.1,Hair disorder,17016099,3
3,22.1,Hair texture abnormal,17016099,3
0,22.1,Death,17016108,
0,22.1,Recurrent cancer,17016135,6
0,22.1,Death,17016137,5
0,22.1,Interstitial lung disease,17016139,5
1,22.1,Eczema,17016139,3
0,22.1,Alopecia,17016156,3
1,22.1,Madarosis,17016156,3
2,22.1,Hair texture abnormal,17016156,3
3,22.1,Hair disorder,17016156,3
4,22.1,Hair colour changes,17016156,3
0,22.1,Hair texture abnormal,17016164,3
1,22.1,Alopecia,17016164,3
2,22.1,Hair disorder,17016164,3
3,22.1,Hair colour changes,17016164,3
4,22.1,Depression,17016164,6
0,22.1,Haematocrit decreased,17016172,3
1,22.1,Red cell distribution width increased,17016172,3
2,22.1,Ulcer,17016172,3
3,22.1,Haemoglobin decreased,17016172,3
4,22.1,White blood cell count increased,17016172,3
5,22.1,Bacterial infection,17016172,3
6,22.1,Infusion related reaction,17016172,3
7,22.1,Mean cell haemoglobin concentration decreased,17016172,3
8,22.1,Neutrophil count increased,17016172,3
9,22.1,Mean cell haemoglobin decreased,17016172,3
10,22.1,Red blood cell count decreased,17016172,3
0,22.1,Pneumonia,17016175,6
1,22.1,Neoplasm progression,17016175,6
2,22.1,Vomiting,17016175,6
3,22.1,Death,17016175,5
4,22.1,Aspiration,17016175,6
5,22.1,Haematemesis,17016175,6
0,22.1,Abdominal rigidity,17016180,3
1,22.1,Infusion related reaction,17016180,3
2,22.1,Musculoskeletal disorder,17016180,3
3,22.1,Epistaxis,17016180,3
4,22.1,Fatigue,17016180,3
5,22.1,Migraine,17016180,3
6,22.1,Nasopharyngitis,17016180,3
7,22.1,Blood pressure increased,17016180,3
8,22.1,Pyrexia,17016180,3
0,22.1,Urinary tract obstruction,17016183,3
1,22.1,Diarrhoea,17016183,3
2,22.1,Haemorrhage,17016183,3
3,22.1,Impaired healing,17016183,3
4,22.1,Lymphadenopathy,17016183,3
5,22.1,Nausea,17016183,3
6,22.1,Blood creatinine increased,17016183,3
7,22.1,Dehydration,17016183,3
8,22.1,Fatigue,17016183,3
9,22.1,Thrombosis,17016183,3
10,22.1,Wound infection,17016183,3
0,22.1,Pollakiuria,17016186,6
0,22.1,Abdominal distension,17016187,3
1,22.1,Feeling abnormal,17016187,3
2,22.1,Hyperhidrosis,17016187,3
3,22.1,Inflammation,17016187,3
4,22.1,Vaginal infection,17016187,3
5,22.1,Asthenia,17016187,3
6,22.1,Arthropathy,17016187,3
7,22.1,Hunger,17016187,3
8,22.1,Neoplasm progression,17016187,3
9,22.1,Blood test abnormal,17016187,3
10,22.1,Urinary incontinence,17016187,3
11,22.1,Blood glucose increased,17016187,3
12,22.1,Diarrhoea,17016187,3
0,22.1,Pulmonary embolism,17016190,6
0,22.1,Gastrointestinal haemorrhage,17016193,6
0,22.1,Paraesthesia,17016203,3
1,22.1,Abdominal pain,17016203,3
2,22.1,Second primary malignancy,17016203,3
3,22.1,Sneezing,17016203,3
4,22.1,Rhinorrhoea,17016203,3
5,22.1,Thrombosis,17016203,3
6,22.1,Insomnia,17016203,3
7,22.1,Hypoaesthesia,17016203,3
8,22.1,Neoplasm malignant,17016203,3
0,22.1,Muscle spasms,17016255,1
1,22.1,Laryngospasm,17016255,1
0,22.1,Blood glucose increased,17016263,1
1,22.1,Glycosylated haemoglobin increased,17016263,1
2,22.1,Rash,17016263,1
0,22.1,Dermatitis acneiform,17016265,3
1,22.1,Ileus,17016265,2
0,22.1,Neoplasm progression,17016269,6
0,22.1,Neoplasm progression,17016270,6
1,22.1,Stress,17016270,6
0,22.1,Neoplasm progression,17016272,6
1,22.1,Constipation,17016272,6
2,22.1,Peripheral swelling,17016272,6
0,22.1,Alopecia,17016302,3
1,22.1,Hair texture abnormal,17016302,3
2,22.1,Madarosis,17016302,3
3,22.1,Hair colour changes,17016302,3
4,22.1,Hair disorder,17016302,3
0,22.1,Product prescribing error,17016305,6
1,22.1,Leukopenia,17016305,6
0,22.1,Pancytopenia,17016320,1
1,22.1,Thrombocytopenia,17016320,1
2,22.1,Anaemia,17016320,2
3,22.1,Leukopenia,17016320,1
0,22.1,Pseudomonal sepsis,17016337,5
1,22.1,Respiratory failure,17016337,5
0,22.1,Ileus paralytic,17016343,5
1,22.1,Hypotension,17016343,5
2,22.1,Bone marrow failure,17016343,5
3,22.1,Intestinal perforation,17016343,1
0,22.1,Neoplasm progression,17016346,6
1,22.1,Dizziness,17016346,6
0,22.1,Drug ineffective,17016366,6
1,22.1,Blood thyroid stimulating hormone increased,17016366,3
0,22.1,Bone marrow failure,17016375,2
1,22.1,Liver injury,17016375,2
0,22.1,Myelitis,17016400,6
0,22.1,Peripheral swelling,17016405,
1,22.1,Blister,17016405,
2,22.1,Product use in unapproved indication,17016405,
3,22.1,Off label use,17016405,
0,22.1,Memory impairment,17016451,6
0,22.1,Neoplasm progression,17016460,6
0,22.1,Neoplasm progression,17016461,6
0,22.1,Neoplasm progression,17016466,6
0,22.1,No adverse event,17016479,6
0,22.1,Neoplasm progression,17016480,6
0,22.1,Death,17016492,5
1,22.1,Anaemia,17016492,6
2,22.1,Neoplasm progression,17016492,6
0,22.1,Blood count abnormal,17016497,6
1,22.1,Eating disorder,17016497,6
2,22.1,Feeling abnormal,17016497,6
3,22.1,Decreased appetite,17016497,6
4,22.1,White blood cell count decreased,17016497,6
0,22.1,Retinal haemorrhage,17016541,1
0,22.1,Bacterial infection,17016576,6
1,22.1,Neoplasm progression,17016576,6
2,22.1,Cyst,17016576,6
3,22.1,Feeling abnormal,17016576,6
4,22.1,Infection,17016576,6
5,22.1,Rectal abscess,17016576,6
0,22.1,Periorbital swelling,17016577,6
1,22.1,Pallor,17016577,6
2,22.1,Peripheral swelling,17016577,2
3,22.1,Lip dry,17016577,6
4,22.1,Thirst,17016577,6
0,22.1,Gastric disorder,17016580,6
0,22.1,Blood count abnormal,17016589,6
0,22.1,Tumour marker increased,17016602,6
0,22.1,Dehydration,17016603,6
1,22.1,Immune system disorder,17016603,6
2,22.1,Arthralgia,17016603,6
3,22.1,Hypotension,17016603,6
4,22.1,Movement disorder,17016603,6
5,22.1,Thinking abnormal,17016603,6
6,22.1,Mouth ulceration,17016603,3
7,22.1,Pyrexia,17016603,6
8,22.1,Weight decreased,17016603,6
9,22.1,Feeling abnormal,17016603,6
10,22.1,Malaise,17016603,6
11,22.1,Headache,17016603,3
0,22.1,Disease progression,17016608,
1,22.1,Metastasis,17016608,
0,22.1,White blood cell count decreased,17016612,6
1,22.1,Pain in extremity,17016612,6
0,22.1,Malaise,17016615,2
0,22.1,Pleural effusion,17016643,5
1,22.1,Oxygen saturation decreased,17016643,5
2,22.1,Sinus tachycardia,17016643,5
3,22.1,Depressed level of consciousness,17016643,5
0,22.1,Diarrhoea,17016644,1
1,22.1,Neutropenia,17016644,1
2,22.1,Alopecia,17016644,1
3,22.1,Polyarthritis,17016644,1
4,22.1,Oesophagitis,17016644,6
5,22.1,Asthenia,17016644,1
6,22.1,Hypokalaemia,17016644,1
7,22.1,Decreased appetite,17016644,1
8,22.1,Influenza,17016644,1
0,22.1,Infection,17016646,3
1,22.1,Post procedural infection,17016646,3
2,22.1,Stomatitis,17016646,3
3,22.1,Decreased appetite,17016646,3
4,22.1,Nausea,17016646,3
5,22.1,Neuralgia,17016646,3
6,22.1,Vomiting,17016646,3
7,22.1,Neuropathy peripheral,17016646,3
8,22.1,Diarrhoea,17016646,3
0,22.1,Dysgeusia,17016649,6
1,22.1,Hypersensitivity,17016649,6
2,22.1,Fatigue,17016649,6
0,22.1,Liver function test increased,17016654,4
1,22.1,White blood cell count decreased,17016654,6
0,22.1,Hypertension,17016655,1
0,22.1,Neuropathy peripheral,17016660,6
1,22.1,Hypoaesthesia,17016660,6
2,22.1,Paraesthesia,17016660,6
0,22.1,Liver disorder,17016661,6
0,22.1,Neuropathy peripheral,17016662,6
0,22.1,Platelet count decreased,17016663,
1,22.1,Metastases to lung,17016663,5
2,22.1,Hepatic function abnormal,17016663,
3,22.1,Palmar-plantar erythrodysaesthesia syndrome,17016663,
4,22.1,Hypertension,17016663,
0,22.1,Metastases to skin,17016666,5
1,22.1,Platelet count decreased,17016666,6
2,22.1,Off label use,17016666,
3,22.1,Metastases to lung,17016666,5
4,22.1,Hepatic function abnormal,17016666,6
5,22.1,Metastases to liver,17016666,5
0,22.1,Colorectal cancer recurrent,17016677,
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,17016677,
2,22.1,Nasopharyngitis,17016677,
3,22.1,Hypertension,17016677,
0,22.1,Hyperglycaemia,17016699,1
1,22.1,Decreased appetite,17016699,1
0,22.1,Death,17016737,5
0,22.1,Lip disorder,17016755,6
1,22.1,Paresis,17016755,6
2,22.1,Nausea,17016755,6
3,22.1,Drug ineffective,17016755,6
4,22.1,Metastases to meninges,17016755,6
5,22.1,Eyelid ptosis,17016755,6
6,22.1,Death,17016755,5
7,22.1,Gait disturbance,17016755,6
8,22.1,Headache,17016755,6
0,22.1,Infection,17016801,1
0,22.1,Interstitial lung disease,17016814,
0,22.1,Intentional product use issue,17016816,6
1,22.1,Death,17016816,5
0,22.1,Death,17016817,5
1,22.1,Intentional product use issue,17016817,6
0,22.1,Deafness,17016869,3
0,22.1,Death,17016881,5
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,17016881,6
0,22.1,Renal failure,17016898,5
1,22.1,Fatigue,17016898,3
2,22.1,Abdominal pain,17016898,3
3,22.1,Myalgia,17016898,3
4,22.1,Dehydration,17016898,3
5,22.1,Decreased appetite,17016898,3
6,22.1,Infection,17016898,5
7,22.1,Blood pressure increased,17016898,3
8,22.1,Haemorrhoids,17016898,3
9,22.1,Ascites,17016898,6
10,22.1,Asthenia,17016898,3
11,22.1,Haemorrhoidal haemorrhage,17016898,3
12,22.1,Pain,17016898,3
0,22.1,Decreased appetite,17016902,1
1,22.1,Mucosal inflammation,17016902,1
0,22.1,Neuropathy peripheral,17016904,6
0,22.1,Toxicity to various agents,17016906,1
1,22.1,Hypertension,17016906,1
2,22.1,Rectal haemorrhage,17016906,1
3,22.1,Tooth abscess,17016906,1
4,22.1,Proteinuria,17016906,1
5,22.1,Palmar-plantar erythrodysaesthesia syndrome,17016906,1
0,22.1,Urinary tract infection,17016907,3
1,22.1,Back pain,17016907,3
2,22.1,Fall,17016907,3
3,22.1,Muscular weakness,17016907,3
4,22.1,Full blood count decreased,17016907,3
5,22.1,Joint injury,17016907,3
6,22.1,Upper limb fracture,17016907,3
0,22.1,Rectal haemorrhage,17016909,6
0,22.1,Asthenia,17016911,6
1,22.1,Abdominal discomfort,17016911,6
2,22.1,Rash,17016911,6
3,22.1,Dry mouth,17016911,6
4,22.1,Volvulus,17016911,6
5,22.1,Neuropathy peripheral,17016911,6
6,22.1,Blood test abnormal,17016911,6
7,22.1,Hepatic infection,17016911,6
0,22.1,Neuropathy peripheral,17016913,1
1,22.1,Device malfunction,17016913,1
2,22.1,Mucosal inflammation,17016913,1
3,22.1,Drug hypersensitivity,17016913,1
0,22.1,Haematotoxicity,17016914,6
0,22.1,Rash,17016916,6
1,22.1,Hot flush,17016916,6
2,22.1,Influenza like illness,17016916,1
3,22.1,Alopecia,17016916,6
4,22.1,Diarrhoea,17016916,1
5,22.1,Epistaxis,17016916,6
6,22.1,Device related infection,17016916,1
7,22.1,Mucosal inflammation,17016916,6
8,22.1,Fatigue,17016916,6
9,22.1,Anaemia,17016916,1
10,22.1,Sepsis,17016916,6
11,22.1,Lymphoedema,17016916,6
12,22.1,Ejection fraction decreased,17016916,1
13,22.1,Gingival swelling,17016916,6
14,22.1,Gastrooesophageal reflux disease,17016916,6
0,22.1,Pain,17016922,3
1,22.1,Weight decreased,17016922,3
2,22.1,Constipation,17016922,3
3,22.1,Dermatitis contact,17016922,3
4,22.1,Nausea,17016922,3
5,22.1,Blood pressure diastolic decreased,17016922,3
6,22.1,Body temperature decreased,17016922,3
7,22.1,Hypotension,17016922,3
8,22.1,Neuralgia,17016922,3
9,22.1,Weight increased,17016922,3
0,22.1,Weight decreased,17016924,2
1,22.1,Decreased appetite,17016924,2
2,22.1,Blood pressure increased,17016924,6
3,22.1,Heart rate increased,17016924,6
4,22.1,Infection,17016924,6
0,22.1,Gastritis haemorrhagic,17016971,1
0,22.1,Diarrhoea,17016977,2
1,22.1,Rash,17016977,3
0,22.1,Hyperchlorhydria,17016987,2
1,22.1,Prescribed underdose,17016987,6
2,22.1,Off label use,17016987,6
3,22.1,Diarrhoea,17016987,2
0,22.1,Exfoliative rash,17016988,1
1,22.1,Vitiligo,17016988,1
0,22.1,Drug ineffective,17016995,6
0,22.1,Globulins decreased,17017026,1
1,22.1,Bronchial disorder,17017026,1
2,22.1,Hip fracture,17017026,1
0,22.1,Haematochezia,17017028,6
1,22.1,Nausea,17017028,6
2,22.1,Therapeutic product ineffective,17017028,6
3,22.1,Temperature intolerance,17017028,6
4,22.1,Unevaluable event,17017028,6
5,22.1,Fatigue,17017028,6
6,22.1,Haemorrhage,17017028,6
7,22.1,Paraesthesia,17017028,6
0,22.1,Interstitial lung disease,17017066,2
1,22.1,Malignant neoplasm progression,17017066,6
0,22.1,Dyskinesia,17017072,2
1,22.1,Headache,17017072,2
2,22.1,Photophobia,17017072,2
3,22.1,Toxicity to various agents,17017072,2
4,22.1,Chorea,17017072,2
5,22.1,Visual impairment,17017072,2
6,22.1,Ataxia,17017072,2
7,22.1,Labelled drug-drug interaction medication error,17017072,2
8,22.1,Confusional state,17017072,2
9,22.1,Memory impairment,17017072,2
0,22.1,Fistula,17017090,6
1,22.1,Medical device site reaction,17017090,6
2,22.1,Haemorrhage,17017090,6
0,22.1,Metastases to bone,17017179,6
1,22.1,Metastases to soft tissue,17017179,6
0,22.1,Malignant neoplasm progression,17017188,6
0,22.1,Death,17017192,5
0,22.1,Death,17017198,5
0,22.1,Death,17017236,5
0,22.1,Thymus enlargement,17017299,6
0,22.1,Deafness,17017311,3
0,22.1,Decreased appetite,17017367,3
1,22.1,Blood urine present,17017367,2
2,22.1,Fatigue,17017367,3
0,22.1,Vomiting,17017408,6
1,22.1,Taste disorder,17017408,3
2,22.1,Cough,17017408,6
3,22.1,Panic attack,17017408,2
4,22.1,Device related infection,17017408,1
5,22.1,Bone marrow failure,17017408,6
6,22.1,Nausea,17017408,3
7,22.1,Pleural effusion,17017408,6
8,22.1,Product dose omission,17017408,6
9,22.1,Anaemia,17017408,6
10,22.1,Leukopenia,17017408,6
11,22.1,Thrombocytopenia,17017408,6
0,22.1,Necrosis,17017411,6
1,22.1,Osteopenia,17017411,6
0,22.1,Back pain,17017413,3
1,22.1,Fatigue,17017413,3
2,22.1,Pain,17017413,3
3,22.1,Movement disorder,17017413,3
4,22.1,Feeling abnormal,17017413,3
0,22.1,Weight decreased,17017431,6
1,22.1,Taste disorder,17017431,6
2,22.1,Headache,17017431,6
3,22.1,Hypertension,17017431,6
4,22.1,Vomiting,17017431,6
5,22.1,Fatigue,17017431,6
6,22.1,Nausea,17017431,6
7,22.1,Decreased appetite,17017431,6
0,22.1,Off label use,17017433,6
1,22.1,Decreased appetite,17017433,5
2,22.1,Death,17017433,5
3,22.1,Malignant neoplasm progression,17017433,5
0,22.1,Hemiplegia,17017438,6
1,22.1,Off label use,17017438,6
2,22.1,Cerebral infarction,17017438,3
0,22.1,Tubulointerstitial nephritis,17017455,3
1,22.1,Infectious pleural effusion,17017455,6
2,22.1,Blood creatinine increased,17017455,6
3,22.1,Febrile neutropenia,17017455,6
0,22.1,Sinusitis,17017462,6
1,22.1,Cough,17017462,6
2,22.1,Arthralgia,17017462,6
3,22.1,Hypertension,17017462,2
4,22.1,Musculoskeletal pain,17017462,6
5,22.1,Micturition disorder,17017462,6
6,22.1,Dehydration,17017462,6
7,22.1,Rhinorrhoea,17017462,6
8,22.1,Oropharyngeal pain,17017462,6
0,22.1,Acute respiratory distress syndrome,17017469,5
1,22.1,Interstitial lung disease,17017469,5
0,22.1,Status epilepticus,17017495,1
0,22.1,Death,17017540,5
0,22.1,Sepsis,17017541,5
0,22.1,Clostridium difficile infection,17017545,1
1,22.1,Nausea,17017545,1
2,22.1,Urinary tract infection,17017545,1
3,22.1,Vomiting,17017545,1
4,22.1,White blood cell count increased,17017545,3
5,22.1,Neutropenia,17017545,1
6,22.1,Diarrhoea,17017545,1
0,22.1,Constipation,17017553,3
1,22.1,Diarrhoea,17017553,1
2,22.1,Nausea,17017553,3
0,22.1,Pneumonitis,17017605,1
0,22.1,Death,17017729,5
0,22.1,Mean cell haemoglobin concentration decreased,17017770,6
1,22.1,Red cell distribution width increased,17017770,6
2,22.1,Pruritus,17017770,6
3,22.1,Lip pain,17017770,6
4,22.1,Red blood cell count decreased,17017770,6
5,22.1,Decreased appetite,17017770,6
6,22.1,Weight decreased,17017770,6
7,22.1,Neutrophil count decreased,17017770,6
8,22.1,Basophil count increased,17017770,6
9,22.1,Blood count abnormal,17017770,6
10,22.1,White blood cell count decreased,17017770,6
11,22.1,Haemoglobin decreased,17017770,6
12,22.1,Lip infection,17017770,6
13,22.1,Lip swelling,17017770,6
14,22.1,Vulvovaginal mycotic infection,17017770,3
15,22.1,Eating disorder,17017770,6
16,22.1,Lip haemorrhage,17017770,6
0,22.1,Platelet count decreased,17017771,6
0,22.1,Arthralgia,17017774,3
1,22.1,Arthropathy,17017774,6
2,22.1,Obesity,17017774,3
3,22.1,Gait disturbance,17017774,6
4,22.1,Dysstasia,17017774,6
5,22.1,Memory impairment,17017774,3
6,22.1,Cognitive disorder,17017774,6
7,22.1,Weight abnormal,17017774,6
0,22.1,Neoplasm progression,17017775,6
1,22.1,Intentional product use issue,17017775,6
2,22.1,Blood count abnormal,17017775,6
0,22.1,Alopecia,17017777,6
1,22.1,Fatigue,17017777,6
2,22.1,Decreased appetite,17017777,6
3,22.1,White blood cell count decreased,17017777,6
0,22.1,Dysphonia,17017785,3
0,22.1,Oral pain,17017786,2
1,22.1,Decreased appetite,17017786,2
2,22.1,Fatigue,17017786,2
0,22.1,Hair colour changes,17017787,3
1,22.1,Hair texture abnormal,17017787,3
2,22.1,Alopecia,17017787,3
3,22.1,Hair disorder,17017787,3
0,22.1,Fall,17017788,6
1,22.1,Neoplasm progression,17017788,6
0,22.1,Large intestine infection,17017806,6
1,22.1,Adverse event,17017806,6
0,22.1,Malignant neoplasm progression,17017827,3
1,22.1,Pulmonary haemorrhage,17017827,3
2,22.1,Pneumonia,17017827,3
0,22.1,Malignant neoplasm progression,17017828,5
0,22.1,Decubitus ulcer,17017867,3
1,22.1,Hypokalaemia,17017867,1
2,22.1,Weight increased,17017867,1
3,22.1,Urinary tract infection,17017867,1
4,22.1,International normalised ratio increased,17017867,3
5,22.1,Bronchitis,17017867,1
6,22.1,Cough,17017867,3
7,22.1,Hypomagnesaemia,17017867,1
8,22.1,Aphthous ulcer,17017867,3
9,22.1,Decreased appetite,17017867,3
10,22.1,Nausea,17017867,3
11,22.1,Asthenia,17017867,3
12,22.1,Vitamin D deficiency,17017867,3
13,22.1,Polyneuropathy,17017867,3
14,22.1,General physical health deterioration,17017867,3
15,22.1,Thrombocytopenia,17017867,3
16,22.1,Constipation,17017867,3
17,22.1,Weight decreased,17017867,3
18,22.1,Thoracic vertebral fracture,17017867,3
19,22.1,Hyperglycaemia,17017867,3
20,22.1,Small intestinal obstruction,17017867,1
0,22.1,Paraesthesia,17017869,1
1,22.1,Presyncope,17017869,1
0,22.1,Electrocardiogram QT prolonged,17017871,1
1,22.1,Electrocardiogram QT prolonged,17017871,1
2,22.1,Neutropenia,17017871,1
3,22.1,Neutropenia,17017871,2
0,22.1,Faeces discoloured,17017879,3
1,22.1,Blood potassium decreased,17017879,6
2,22.1,Underdose,17017879,3
3,22.1,Recurrent cancer,17017879,6
0,22.1,Breast cancer recurrent,17017897,6
1,22.1,Transaminases increased,17017897,1
0,22.1,General physical health deterioration,17017902,1
0,22.1,Pneumonitis,17017910,3
1,22.1,Computerised tomogram abnormal,17017910,3
0,22.1,Myocardial ischaemia,17017916,6
0,22.1,Pyrexia,17017963,1
1,22.1,Vision blurred,17017963,6
2,22.1,Escherichia infection,17017963,6
3,22.1,Iridocyclitis,17017963,2
4,22.1,Urosepsis,17017963,6
5,22.1,Vomiting,17017963,3
6,22.1,Vitreous floaters,17017963,6
7,22.1,Diarrhoea,17017963,3
8,22.1,Photopsia,17017963,6
0,22.1,Insomnia,17017967,3
1,22.1,Cough,17017967,3
2,22.1,Peripheral swelling,17017967,3
3,22.1,Thrombosis,17017967,1
4,22.1,Glossodynia,17017967,1
5,22.1,Fatigue,17017967,3
6,22.1,Alopecia,17017967,3
0,22.1,Metastases to liver,17017969,6
1,22.1,Malignant neoplasm progression,17017969,6
2,22.1,Malaise,17017969,6
3,22.1,Metastases to lung,17017969,6
4,22.1,Breast cancer metastatic,17017969,6
5,22.1,Lymphadenopathy,17017969,6
6,22.1,Pyrexia,17017969,6
0,22.1,Immune thrombocytopenic purpura,17017983,6
0,22.1,Hypertension,17017986,3
0,22.1,White blood cell count decreased,17018017,2
1,22.1,Febrile neutropenia,17018017,2
0,22.1,Anaemia,17018020,1
0,22.1,Death,17018026,5
1,22.1,Intentional product use issue,17018026,6
0,22.1,Vomiting,17018076,6
1,22.1,Abdominal discomfort,17018076,6
0,22.1,Skin exfoliation,17018078,6
1,22.1,Thrombosis,17018078,6
2,22.1,Fluid retention,17018078,6
0,22.1,Pain,17018089,2
1,22.1,Abdominal pain upper,17018089,3
2,22.1,Decreased appetite,17018089,1
3,22.1,Hepatic enzyme increased,17018089,2
4,22.1,Vomiting,17018089,1
5,22.1,Gastritis,17018089,1
6,22.1,Pain,17018089,1
7,22.1,Hypersensitivity,17018089,3
0,22.1,Dyspnoea,17018090,4
1,22.1,Dyspnoea,17018090,5
0,22.1,Circulatory collapse,17018208,5
0,22.1,Neutropenia,17018209,1
1,22.1,Wrong technique in product usage process,17018209,6
2,22.1,Incorrect disposal of product,17018209,6
0,22.1,Nephropathy toxic,17018237,1
0,22.1,Death,17018279,5
0,22.1,Death,17018281,5
1,22.1,Adverse drug reaction,17018281,6
0,22.1,Malignant neoplasm progression,17018283,5
0,22.1,Death,17018284,5
0,22.1,No adverse event,17018285,6
0,22.1,Vomiting,17018290,3
1,22.1,Fatigue,17018290,3
2,22.1,Nausea,17018290,3
0,22.1,Fatigue,17018318,2
1,22.1,Diarrhoea,17018318,6
0,22.1,Malaise,17018341,6
1,22.1,Epistaxis,17018341,2
2,22.1,Headache,17018341,6
3,22.1,Swelling face,17018341,1
4,22.1,Stomatitis,17018341,1
5,22.1,Electrocardiogram QT prolonged,17018341,6
6,22.1,Liver function test abnormal,17018341,6
7,22.1,Thrombosis,17018341,6
8,22.1,Oral pain,17018341,2
9,22.1,Blood calcium decreased,17018341,2
10,22.1,Fatigue,17018341,2
0,22.1,Drug delivery system malfunction,17018416,6
0,22.1,Hyperglycaemia,17018428,6
1,22.1,Product use in unapproved indication,17018428,6
0,22.1,Dyspnoea at rest,17018469,6
1,22.1,Pneumocystis jirovecii pneumonia,17018469,6
2,22.1,Cough,17018469,6
3,22.1,Respiratory failure,17018469,6
4,22.1,Dyspnoea exertional,17018469,6
5,22.1,General physical health deterioration,17018469,6
6,22.1,Multiple organ dysfunction syndrome,17018469,5
7,22.1,Pyrexia,17018469,6
0,22.1,Neutropenia,17018473,1
0,22.1,Leukopenia,17018481,3
1,22.1,Neutropenia,17018481,1
2,22.1,Bone pain,17018481,6
3,22.1,Gastritis,17018481,1
4,22.1,Herpes zoster,17018481,1
5,22.1,Gastrointestinal haemorrhage,17018481,1
6,22.1,Neutropenia,17018481,6
7,22.1,Leukopenia,17018481,1
8,22.1,Cough,17018481,1
9,22.1,Large intestinal ulcer,17018481,1
10,22.1,Neutropenia,17018481,3
0,22.1,Osteonecrosis of jaw,17018501,1
0,22.1,Chronic kidney disease,17018562,3
0,22.1,Leukopenia,17018653,1
1,22.1,Granulocytopenia,17018653,1
2,22.1,Neutropenia,17018653,1
3,22.1,Leukopenia,17018653,1
4,22.1,Neutropenia,17018653,1
5,22.1,Pulmonary embolism,17018653,2
0,22.1,Neoplasm malignant,17018659,5
0,22.1,Vitreous haemorrhage,17018674,6
1,22.1,Retinal tear,17018674,6
0,22.1,Interstitial lung disease,17018704,3
0,22.1,Metastases to bone,17018723,6
1,22.1,Malignant neoplasm progression,17018723,6
2,22.1,Breast cancer,17018723,6
3,22.1,Malignant pleural effusion,17018723,6
0,22.1,Vertigo,17018725,3
1,22.1,Gait disturbance,17018725,3
2,22.1,Cerebellar syndrome,17018725,3
3,22.1,Dysmetria,17018725,3
0,22.1,Gait disturbance,17018737,1
1,22.1,Pyrexia,17018737,1
0,22.1,Bone marrow failure,17018739,2
1,22.1,Intentional product use issue,17018739,6
2,22.1,Off label use,17018739,6
0,22.1,Death,17018767,5
0,22.1,Gastric haemorrhage,17018770,1
0,22.1,Malignant neoplasm progression,17018775,5
0,22.1,Vitreous floaters,17018886,2
1,22.1,Asthenia,17018886,2
2,22.1,Diarrhoea,17018886,2
3,22.1,Vomiting,17018886,2
4,22.1,Temporal arteritis,17018886,2
5,22.1,Visual impairment,17018886,2
6,22.1,Pain,17018886,2
7,22.1,Mass,17018886,2
0,22.1,Cerebellar ataxia,17018898,2
0,22.1,Heart rate increased,17018902,6
1,22.1,Loss of personal independence in daily activities,17018902,6
2,22.1,Metastases to central nervous system,17018902,6
3,22.1,Metastases to bone,17018902,6
0,22.1,Takayasu^s arteritis,17018953,1
0,22.1,Thrombocytopenia,17018969,6
1,22.1,Anaemia,17018969,6
2,22.1,Toxicity to various agents,17018969,6
3,22.1,Diarrhoea,17018969,1
0,22.1,Cachexia,17018977,3
0,22.1,Interstitial lung disease,17018982,1
0,22.1,Intentional product use issue,17019027,6
1,22.1,Death,17019027,5
0,22.1,Death,17019028,5
1,22.1,Intentional product use issue,17019028,6
0,22.1,Cerebrovascular accident,17019087,5
1,22.1,Thrombophlebitis migrans,17019087,5
0,22.1,Renal impairment,17019088,6
1,22.1,Stomatitis,17019088,6
2,22.1,Neutrophil count decreased,17019088,6
3,22.1,Decreased appetite,17019088,6
4,22.1,Fatigue,17019088,6
5,22.1,Palmar-plantar erythrodysaesthesia syndrome,17019088,6
6,22.1,Hepatic function abnormal,17019088,6
7,22.1,Neurotoxicity,17019088,6
8,22.1,White blood cell count decreased,17019088,6
9,22.1,Nausea,17019088,6
10,22.1,Haemoglobin decreased,17019088,6
11,22.1,Vomiting,17019088,6
12,22.1,Platelet count decreased,17019088,6
0,22.1,Neutropenia,17019113,6
1,22.1,Delirium,17019113,5
2,22.1,Vomiting,17019113,5
3,22.1,Thrombocytopenia,17019113,6
4,22.1,Sepsis,17019113,6
0,22.1,Tooth abscess,17019130,1
1,22.1,Rash erythematous,17019130,1
2,22.1,Streptococcal sepsis,17019130,1
0,22.1,Sepsis,17019162,6
1,22.1,Abdominal abscess,17019162,6
2,22.1,Embolic stroke,17019162,4
3,22.1,Hyperglycaemia,17019162,1
4,22.1,Atrial fibrillation,17019162,6
5,22.1,Delirium,17019162,6
6,22.1,Generalised oedema,17019162,6
7,22.1,Acute kidney injury,17019162,6
8,22.1,Intestinal perforation,17019162,1
9,22.1,Subdural haematoma,17019162,1
10,22.1,Lactic acidosis,17019162,1
11,22.1,Venous thrombosis limb,17019162,6
12,22.1,Anaemia of chronic disease,17019162,6
13,22.1,Colitis,17019162,1
14,22.1,Malnutrition,17019162,6
0,22.1,Decreased appetite,17019252,3
1,22.1,Dehydration,17019252,3
2,22.1,Haemoglobin decreased,17019252,3
3,22.1,Hypotension,17019252,3
4,22.1,Macrocytosis,17019252,3
5,22.1,Red cell distribution width increased,17019252,3
6,22.1,Weight increased,17019252,3
7,22.1,Blood alkaline phosphatase increased,17019252,3
8,22.1,Blood creatinine increased,17019252,3
9,22.1,Lymphocyte count decreased,17019252,3
10,22.1,Alanine aminotransferase increased,17019252,3
11,22.1,Body temperature decreased,17019252,3
12,22.1,Pneumonia,17019252,3
13,22.1,Mean cell haemoglobin concentration increased,17019252,3
14,22.1,Mean cell volume increased,17019252,3
15,22.1,Red blood cell count decreased,17019252,3
16,22.1,Injection site extravasation,17019252,3
17,22.1,Exostosis of jaw,17019252,3
18,22.1,Gastroenteritis viral,17019252,3
19,22.1,Hyperthermia,17019252,3
20,22.1,Gamma-glutamyltransferase increased,17019252,3
21,22.1,Heart rate decreased,17019252,3
22,22.1,Mean cell haemoglobin increased,17019252,3
23,22.1,Blood alkaline phosphatase decreased,17019252,3
24,22.1,Peripheral swelling,17019252,3
25,22.1,Poor venous access,17019252,3
26,22.1,Protein urine,17019252,3
27,22.1,Pulmonary mass,17019252,3
28,22.1,Aspartate aminotransferase increased,17019252,3
29,22.1,Glomerular filtration rate decreased,17019252,3
30,22.1,Haematocrit decreased,17019252,3
31,22.1,Platelet count decreased,17019252,3
32,22.1,White blood cell count decreased,17019252,3
33,22.1,Neoplasm progression,17019252,3
0,22.1,Dry skin,17019256,3
1,22.1,Weight decreased,17019256,3
2,22.1,Bacteraemia,17019256,3
3,22.1,Dysuria,17019256,3
4,22.1,Immunosuppression,17019256,3
5,22.1,Prostatomegaly,17019256,3
6,22.1,Sepsis,17019256,3
7,22.1,Urinary tract infection,17019256,3
8,22.1,Urinary retention,17019256,3
9,22.1,Headache,17019256,3
10,22.1,Insomnia,17019256,3
11,22.1,Skin fragility,17019256,3
12,22.1,Somnolence,17019256,3
13,22.1,Fingerprint loss,17019256,3
14,22.1,Palmar-plantar erythrodysaesthesia syndrome,17019256,3
15,22.1,Diarrhoea,17019256,3
16,22.1,Stomatitis,17019256,3
17,22.1,Neutrophil count decreased,17019256,3
0,22.1,Death,17019311,5
0,22.1,Hypokalaemia,17019322,2
0,22.1,Intentional product use issue,17019360,6
1,22.1,Death,17019360,5
0,22.1,Duodenal perforation,17019400,1
1,22.1,Staphylococcal sepsis,17019400,1
2,22.1,Wound infection,17019400,1
3,22.1,Enterococcal infection,17019400,1
4,22.1,Staphylococcal infection,17019400,1
0,22.1,Embolism,17019405,1
0,22.1,Arthralgia,17019420,6
1,22.1,Prostate cancer metastatic,17019420,6
2,22.1,Musculoskeletal chest pain,17019420,6
3,22.1,Herpes zoster,17019420,6
4,22.1,Spinal pain,17019420,6
5,22.1,Pneumonia,17019420,3
0,22.1,Hepatic failure,17019433,6
1,22.1,Bone marrow failure,17019433,6
2,22.1,Renal failure,17019433,6
0,22.1,Ascites,17019444,2
0,22.1,Pain,17019453,6
1,22.1,Abdominal pain upper,17019453,6
2,22.1,Nausea,17019453,6
3,22.1,Decreased appetite,17019453,6
0,22.1,Dysphagia,17019455,3
1,22.1,Product dose omission,17019455,6
2,22.1,Oral pain,17019455,3
3,22.1,Pain,17019455,6
4,22.1,Rash,17019455,6
0,22.1,Drug ineffective,17019462,6
0,22.1,Pulmonary toxicity,17019466,6
0,22.1,Intentional product use issue,17019468,6
1,22.1,Off label use,17019468,6
2,22.1,Myocardial infarction,17019468,5
0,22.1,Pleural effusion,17019481,6
1,22.1,Peripheral swelling,17019481,6
0,22.1,Neck pain,17019497,1
0,22.1,Injection site nodule,17019499,2
1,22.1,Dyspnoea exertional,17019499,3
2,22.1,Gastric ulcer haemorrhage,17019499,3
3,22.1,Fatigue,17019499,3
4,22.1,Pyrexia,17019499,6
5,22.1,Incorrect product administration duration,17019499,3
6,22.1,Hot flush,17019499,3
7,22.1,Nocturia,17019499,3
8,22.1,Incorrect drug administration rate,17019499,3
9,22.1,Burning sensation,17019499,1
10,22.1,Injection site swelling,17019499,2
11,22.1,Weight decreased,17019499,3
12,22.1,Injection site mass,17019499,3
13,22.1,Product administered at inappropriate site,17019499,6
14,22.1,Myalgia,17019499,1
15,22.1,Weight increased,17019499,3
16,22.1,Coronary artery occlusion,17019499,3
17,22.1,Myocardial infarction,17019499,3
18,22.1,Injection site pain,17019499,3
19,22.1,Vertigo,17019499,3
20,22.1,Dysstasia,17019499,3
21,22.1,Constipation,17019499,3
22,22.1,Oedema,17019499,3
0,22.1,Pneumothorax,17019500,6
0,22.1,Polyarthritis,17019578,2
0,22.1,Platelet count decreased,17019591,6
1,22.1,Death,17019591,5
2,22.1,Decreased appetite,17019591,6
0,22.1,Blindness,17019678,6
0,22.1,Death,17019703,5
0,22.1,Hepatic failure,17019732,2
1,22.1,Overdose,17019732,1
2,22.1,Duplicate therapy error,17019732,1
3,22.1,Thrombocytopenia,17019732,2
0,22.1,Mouth injury,17019814,2
1,22.1,Enteritis infectious,17019814,2
2,22.1,Diarrhoea,17019814,2
3,22.1,Malaise,17019814,2
4,22.1,Abdominal pain upper,17019814,2
5,22.1,Vomiting,17019814,2
6,22.1,Feeling abnormal,17019814,2
0,22.1,Bile duct obstruction,17019840,6
0,22.1,Decreased appetite,17019848,3
1,22.1,Hydrocephalus,17019848,3
2,22.1,Taste disorder,17019848,3
3,22.1,Diarrhoea,17019848,3
4,22.1,Nausea,17019848,1
5,22.1,Pericardial effusion,17019848,3
6,22.1,Haemorrhage,17019848,3
7,22.1,Stomatitis,17019848,3
8,22.1,Blood pressure increased,17019848,1
9,22.1,Fatigue,17019848,3
10,22.1,Impaired quality of life,17019848,3
11,22.1,Vomiting,17019848,1
12,22.1,Weight decreased,17019848,3
13,22.1,Oral pain,17019848,3
0,22.1,Hepatocellular injury,17019853,1
1,22.1,Vomiting,17019853,1
0,22.1,Blood pressure increased,17019861,6
1,22.1,Constipation,17019861,6
2,22.1,Dysphonia,17019861,6
3,22.1,Productive cough,17019861,6
4,22.1,Abdominal pain upper,17019861,6
5,22.1,Abdominal distension,17019861,6
6,22.1,Pain,17019861,6
0,22.1,Cerebrovascular accident,17019910,1
0,22.1,Colorectal cancer,17019921,3
0,22.1,Death,17019948,5
0,22.1,Suicidal ideation,17019962,1
1,22.1,Crying,17019962,6
2,22.1,Feeding disorder,17019962,6
3,22.1,Sleep disorder,17019962,6
4,22.1,Personality change,17019962,1
0,22.1,Fatigue,17020046,6
1,22.1,Diarrhoea,17020046,6
2,22.1,Dizziness,17020046,6
3,22.1,Nausea,17020046,6
4,22.1,Hypotension,17020046,6
5,22.1,Abdominal pain,17020046,6
6,22.1,Weight decreased,17020046,6
0,22.1,Influenza,17020068,1
0,22.1,Product dose omission,17020073,6
1,22.1,Lung neoplasm,17020073,6
0,22.1,Rash,17020075,6
1,22.1,Tongue discomfort,17020075,6
2,22.1,Drug ineffective,17020075,6
0,22.1,Prescribed overdose,17020095,6
1,22.1,Drug resistance,17020095,6
2,22.1,Acquired gene mutation,17020095,6
3,22.1,Malignant neoplasm progression,17020095,6
0,22.1,Dermatitis bullous,17020115,2
0,22.1,Chest wall abscess,17020135,6
1,22.1,Abscess limb,17020135,6
2,22.1,Breast abscess,17020135,6
3,22.1,Wound infection,17020135,6
4,22.1,Arthritis bacterial,17020135,6
5,22.1,Subcutaneous abscess,17020135,6
6,22.1,Abscess,17020135,6
7,22.1,Vaginal abscess,17020135,6
8,22.1,Cellulitis,17020135,6
9,22.1,Tooth abscess,17020135,6
10,22.1,Seroma,17020135,6
11,22.1,Paronychia,17020135,6
12,22.1,Folliculitis,17020135,6
13,22.1,Enterobacter infection,17020135,6
14,22.1,Staphylococcal infection,17020135,6
0,22.1,Metastases to lymph nodes,17020141,2
1,22.1,Breast cancer recurrent,17020141,2
0,22.1,Product dose omission,17020148,3
1,22.1,Syringe issue,17020148,6
0,22.1,Prostate cancer,17020163,6
1,22.1,Drug ineffective,17020163,6
0,22.1,Product size issue,17020164,6
1,22.1,Dysphagia,17020164,6
2,22.1,Incorrect dose administered,17020164,6
0,22.1,General physical health deterioration,17020194,6
1,22.1,Product dose omission,17020194,6
2,22.1,Underdose,17020194,6
0,22.1,Anaemia,17020252,3
1,22.1,Anaemia,17020252,1
0,22.1,Neurological symptom,17020264,3
1,22.1,Cerebral radiation injury,17020264,6
0,22.1,Myalgia,17020283,2
1,22.1,Myositis,17020283,2
2,22.1,Ketoacidosis,17020283,1
3,22.1,Fulminant type 1 diabetes mellitus,17020283,1
4,22.1,Autoimmune hepatitis,17020283,2
5,22.1,Blood creatine phosphokinase increased,17020283,2
0,22.1,Palpitations,17020308,1
1,22.1,Product dose omission,17020308,6
2,22.1,Dermatitis allergic,17020308,6
3,22.1,Erythema,17020308,6
4,22.1,Pruritus,17020308,6
0,22.1,Osteomyelitis,17020318,6
1,22.1,Neoplasm progression,17020318,6
2,22.1,Dysphagia,17020318,6
0,22.1,Blood creatinine increased,17020324,3
1,22.1,Haemoglobin decreased,17020324,3
2,22.1,Acute kidney injury,17020324,3
3,22.1,Platelet count decreased,17020324,3
4,22.1,Bone marrow toxicity,17020324,3
0,22.1,Abdominal pain,17020375,1
1,22.1,Mastitis,17020375,1
0,22.1,ECG signs of myocardial infarction,17020392,6
1,22.1,Ventricular hypertrophy,17020392,6
0,22.1,Fatigue,17020490,3
1,22.1,Glomerular filtration rate decreased,17020490,3
2,22.1,Nausea,17020490,6
3,22.1,Coma,17020490,5
0,22.1,Off label use,17020527,6
1,22.1,Recurrent cancer,17020527,6
2,22.1,Gastrointestinal toxicity,17020527,6
0,22.1,Drug ineffective,17020536,6
1,22.1,Recurrent cancer,17020536,6
2,22.1,Disease progression,17020536,6
0,22.1,Nasopharyngitis,17020545,6
1,22.1,Diarrhoea,17020545,4
2,22.1,Nausea,17020545,4
3,22.1,Seasonal allergy,17020545,3
4,22.1,Fatigue,17020545,2
5,22.1,Blood sodium decreased,17020545,1
6,22.1,Cough,17020545,6
7,22.1,Vomiting,17020545,4
8,22.1,Recurrent cancer,17020545,3
9,22.1,Memory impairment,17020545,2
10,22.1,Anxiety,17020545,6
11,22.1,Sinus disorder,17020545,6
0,22.1,Recurrent cancer,17020553,6
1,22.1,Thrombocytopenia,17020553,6
2,22.1,Drug ineffective,17020553,6
0,22.1,Thrombocytopenia,17020555,6
1,22.1,Recurrent cancer,17020555,6
0,22.1,Respiratory failure,17020557,6
1,22.1,Pneumonia,17020557,6
0,22.1,Interstitial lung disease,17020566,5
1,22.1,Encephalitis,17020566,5
0,22.1,Hyperuricaemia,17020597,1
1,22.1,Gout,17020597,6
0,22.1,Death,17020637,5
0,22.1,Gait disturbance,17020642,3
1,22.1,Vertigo,17020642,3
2,22.1,Cerebellar syndrome,17020642,3
3,22.1,Dysmetria,17020642,3
0,22.1,Hot flush,17020658,3
0,22.1,Fatigue,17020659,6
1,22.1,Hot flush,17020659,6
0,22.1,Dizziness,17020689,3
1,22.1,Mitral valve stenosis,17020689,3
2,22.1,Cystitis,17020689,1
3,22.1,Hyperthyroidism,17020689,1
4,22.1,Fatigue,17020689,3
5,22.1,General physical health deterioration,17020689,1
6,22.1,Insomnia,17020689,1
7,22.1,Microangiopathy,17020689,6
8,22.1,Cardiac hypertrophy,17020689,6
9,22.1,Tricuspid valve incompetence,17020689,3
10,22.1,Thrombocytopenia,17020689,1
11,22.1,Renal failure,17020689,5
12,22.1,Nausea,17020689,1
0,22.1,Renal failure,17020732,6
0,22.1,Leukopenia,17020745,6
0,22.1,Off label use,17020768,6
1,22.1,Product use in unapproved indication,17020768,6
2,22.1,Herpes zoster,17020768,1
0,22.1,Nausea,17020769,
1,22.1,Glossodynia,17020769,
0,22.1,Non-small cell lung cancer,17020812,6
1,22.1,Malignant neoplasm progression,17020812,6
2,22.1,Metastases to central nervous system,17020812,6
0,22.1,Haematemesis,17020837,6
1,22.1,Drug resistance,17020837,6
2,22.1,Metastases to bone,17020837,6
3,22.1,Purulent discharge,17020837,6
4,22.1,Mucosal inflammation,17020837,6
5,22.1,Malignant neoplasm progression,17020837,6
6,22.1,Skin injury,17020837,6
0,22.1,Hip fracture,17020882,6
1,22.1,Fall,17020882,1
0,22.1,Metastases to bone,17020889,6
0,22.1,Cardiac arrest,17020904,5
1,22.1,Tracheal haemorrhage,17020904,5
0,22.1,Malignant neoplasm progression,17020917,6
1,22.1,Drug resistance,17020917,6
0,22.1,Immune-mediated nephritis,17020934,2
0,22.1,Off label use,17020984,6
1,22.1,Osteonecrosis of jaw,17020984,1
2,22.1,Product use in unapproved indication,17020984,6
0,22.1,Acute kidney injury,17020988,2
1,22.1,Condition aggravated,17020988,2
0,22.1,Hypoaesthesia,17021013,6
1,22.1,Product use in unapproved indication,17021013,6
2,22.1,Skin cancer,17021013,6
3,22.1,Malignant neoplasm progression,17021013,6
0,22.1,Hepatic enzyme increased,17021035,6
1,22.1,Neuropathy peripheral,17021035,6
2,22.1,Fatigue,17021035,6
3,22.1,Flatulence,17021035,6
4,22.1,Nasopharyngitis,17021035,6
5,22.1,Lymphocyte count decreased,17021035,6
6,22.1,Nausea,17021035,6
0,22.1,Product use in unapproved indication,17021038,6
1,22.1,Off label use,17021038,6
2,22.1,Death,17021038,5
3,22.1,Neoplasm progression,17021038,6
0,22.1,Cardiac failure,17021066,2
1,22.1,Myocarditis,17021066,2
0,22.1,Taste disorder,17021080,1
1,22.1,Diarrhoea,17021080,1
2,22.1,Blood pressure systolic increased,17021080,6
3,22.1,Product use in unapproved indication,17021080,6
4,22.1,Fatigue,17021080,6
0,22.1,Interstitial lung disease,17021126,1
1,22.1,Hypoglycaemia,17021126,1
2,22.1,Dumping syndrome,17021126,6
3,22.1,Vertigo,17021126,1
4,22.1,Diarrhoea,17021126,1
5,22.1,Enterocolitis,17021126,6
6,22.1,Diarrhoea,17021126,1
0,22.1,Immune-mediated nephritis,17021132,1
1,22.1,White blood cell count decreased,17021132,1
2,22.1,Anaemia,17021132,2
3,22.1,Platelet count decreased,17021132,6
0,22.1,Dyspnoea,17021137,6
1,22.1,Rash,17021137,6
2,22.1,Peripheral swelling,17021137,6
3,22.1,Urticaria,17021137,6
4,22.1,Oropharyngeal pain,17021137,3
5,22.1,Blood pressure measurement,17021137,6
6,22.1,Chest discomfort,17021137,6
7,22.1,Dizziness,17021137,6
0,22.1,Neoplasm progression,17021145,6
0,22.1,Hospitalisation,17021182,6
1,22.1,Underdose,17021182,6
0,22.1,Death,17021257,5
0,22.1,Death,17021262,5
0,22.1,Renal failure,17021267,
1,22.1,Acidosis,17021267,
2,22.1,Vomiting,17021267,
3,22.1,Diarrhoea,17021267,
4,22.1,Full blood count decreased,17021267,
0,22.1,Alopecia,17021272,3
0,22.1,Alopecia,17021279,3
1,22.1,Product use in unapproved indication,17021279,6
2,22.1,Madarosis,17021279,3
3,22.1,Off label use,17021279,6
0,22.1,Computerised tomogram abnormal,17021283,6
1,22.1,Neoplasm recurrence,17021283,6
2,22.1,Anxiety,17021283,6
3,22.1,Alopecia,17021283,6
4,22.1,Feeling abnormal,17021283,6
5,22.1,Red blood cell count decreased,17021283,6
6,22.1,Discomfort,17021283,6
7,22.1,Neutropenia,17021283,6
8,22.1,White blood cell count decreased,17021283,6
0,22.1,Neutropenia,17021291,6
1,22.1,Neoplasm progression,17021291,1
0,22.1,White blood cell count decreased,17021321,6
0,22.1,Musculoskeletal pain,17021332,3
1,22.1,Dyspepsia,17021332,1
2,22.1,Fatigue,17021332,3
3,22.1,Back pain,17021332,3
4,22.1,Localised infection,17021332,1
5,22.1,Abdominal pain,17021332,3
6,22.1,Axillary pain,17021332,3
7,22.1,Blindness,17021332,3
8,22.1,Cancer pain,17021332,1
9,22.1,Decreased appetite,17021332,1
10,22.1,Urinary tract infection,17021332,6
11,22.1,Productive cough,17021332,3
12,22.1,Iron deficiency,17021332,1
13,22.1,Depressed mood,17021332,3
14,22.1,Nyctalgia,17021332,3
15,22.1,Polyneuropathy,17021332,3
16,22.1,Hypersensitivity,17021332,3
17,22.1,Pyuria,17021332,1
18,22.1,Bone contusion,17021332,3
19,22.1,Anaemia,17021332,3
20,22.1,Hyperhidrosis,17021332,6
21,22.1,Nausea,17021332,3
22,22.1,Pain in extremity,17021332,1
23,22.1,Dry mouth,17021332,3
24,22.1,Cough,17021332,3
25,22.1,Abdominal pain upper,17021332,3
0,22.1,Thrombocytopenia,17021337,1
1,22.1,Aphthous ulcer,17021337,1
2,22.1,Neutropenia,17021337,1
0,22.1,Polyneuropathy,17021342,3
1,22.1,Dysphagia,17021342,3
2,22.1,Rhinorrhoea,17021342,1
3,22.1,Back pain,17021342,3
0,22.1,Chills,17021374,1
1,22.1,Feeling cold,17021374,6
2,22.1,Hot flush,17021374,6
3,22.1,Fine motor skill dysfunction,17021374,6
0,22.1,Neoplasm progression,17021379,6
0,22.1,Alopecia,17021387,3
1,22.1,Anxiety,17021387,6
2,22.1,Hair colour changes,17021387,3
3,22.1,Hair disorder,17021387,3
4,22.1,Hair texture abnormal,17021387,3
0,22.1,Depression,17021400,6
1,22.1,Madarosis,17021400,3
2,22.1,Alopecia,17021400,3
0,22.1,Neoplasm progression,17021402,
0,22.1,Nausea,17021403,6
1,22.1,Diarrhoea,17021403,6
2,22.1,Tooth infection,17021403,6
3,22.1,Renal failure,17021403,6
4,22.1,Vomiting,17021403,6
5,22.1,Dehydration,17021403,6
6,22.1,Fatigue,17021403,6
0,22.1,Arthralgia,17021405,1
1,22.1,Weight increased,17021405,6
2,22.1,Pain,17021405,1
0,22.1,Nasopharyngitis,17021413,6
0,22.1,Alopecia,17021444,1
1,22.1,White blood cell count decreased,17021444,6
2,22.1,Stress,17021444,6
3,22.1,Nervousness,17021444,6
0,22.1,Nausea,17021451,6
1,22.1,Stress,17021451,6
2,22.1,Pruritus,17021451,6
3,22.1,Dry skin,17021451,6
4,22.1,Vomiting,17021451,6
5,22.1,White blood cell count decreased,17021451,6
0,22.1,Neoplasm progression,17021474,6
0,22.1,Blood count abnormal,17021475,
0,22.1,Urinary tract infection,17021483,6
1,22.1,Tooth infection,17021483,6
0,22.1,Rash,17021487,6
0,22.1,Hair texture abnormal,17021493,3
1,22.1,Alopecia,17021493,3
2,22.1,Hair disorder,17021493,3
3,22.1,Hair colour changes,17021493,3
0,22.1,Neutropenia,17021562,6
0,22.1,Neutropenia,17021573,6
0,22.1,Haemorrhage,17021608,3
1,22.1,Syncope,17021608,1
2,22.1,Neuropathy peripheral,17021608,3
3,22.1,Proteinuria,17021608,3
4,22.1,Dysphonia,17021608,3
5,22.1,Diarrhoea,17021608,1
6,22.1,Scab,17021608,3
7,22.1,Fatigue,17021608,3
8,22.1,Anal haemorrhage,17021608,1
9,22.1,Malaise,17021608,3
10,22.1,Constipation,17021608,3
11,22.1,Epistaxis,17021608,3
12,22.1,Nasopharyngitis,17021608,3
13,22.1,Respiratory tract infection,17021608,1
14,22.1,Stomatitis,17021608,1
0,22.1,Urticaria,17021613,1
1,22.1,Hypotension,17021613,1
2,22.1,Palpitations,17021613,1
0,22.1,Death,17021626,
0,22.1,Product administration error,17021628,2
1,22.1,Injection site abscess,17021628,2
0,22.1,Disease progression,17021637,
0,22.1,Disease progression,17021648,5
0,22.1,Therapy cessation,17021652,
0,22.1,Dementia Alzheimer^s type,17021677,6
0,22.1,Malignant neoplasm progression,17021686,6
1,22.1,Osteonecrosis of jaw,17021686,6
2,22.1,Metastases to liver,17021686,6
3,22.1,Metastases to bone,17021686,6
4,22.1,Hypercalcaemia,17021686,6
5,22.1,Asthenia,17021686,6
6,22.1,Bone pain,17021686,6
7,22.1,Breast cancer metastatic,17021686,6
0,22.1,Oxygen saturation decreased,17021736,6
1,22.1,Dyspnoea,17021736,6
2,22.1,Pneumonitis,17021736,6
3,22.1,Hepatitis,17021736,6
0,22.1,Product use issue,17021755,6
1,22.1,Neutropenic sepsis,17021755,1
2,22.1,Off label use,17021755,6
3,22.1,Clostridium difficile infection,17021755,6
0,22.1,Stomatitis,17021776,1
1,22.1,Bone marrow failure,17021776,1
2,22.1,Nausea,17021776,1
3,22.1,White blood cell count decreased,17021776,3
4,22.1,Leukopenia,17021776,1
5,22.1,Fatigue,17021776,1
6,22.1,Diarrhoea,17021776,1
7,22.1,Myalgia,17021776,1
8,22.1,Mucosal inflammation,17021776,1
9,22.1,Dysphonia,17021776,1
10,22.1,Lip swelling,17021776,1
11,22.1,Headache,17021776,1
12,22.1,Oral pain,17021776,1
0,22.1,Death,17021796,5
0,22.1,Death,17021832,5
0,22.1,Taste disorder,17021890,3
1,22.1,Tongue discomfort,17021890,3
2,22.1,Glossodynia,17021890,3
0,22.1,Radiation pneumonitis,17021968,6
0,22.1,Oedema peripheral,17022119,1
1,22.1,Hyperhidrosis,17022119,1
2,22.1,Asthenia,17022119,1
3,22.1,Hot flush,17022119,3
4,22.1,Taste disorder,17022119,1
0,22.1,Onychoclasis,17022164,6
1,22.1,Pain,17022164,3
2,22.1,Nausea,17022164,3
3,22.1,Musculoskeletal disorder,17022164,1
0,22.1,Productive cough,17022189,1
1,22.1,Oedema peripheral,17022189,1
2,22.1,Neutrophil count abnormal,17022189,6
3,22.1,Pyrexia,17022189,1
4,22.1,Rales,17022189,6
5,22.1,Thyroid mass,17022189,6
6,22.1,Lung disorder,17022189,6
7,22.1,Pneumonia,17022189,1
8,22.1,Nasopharyngitis,17022189,1
9,22.1,Pelvic inflammatory disease,17022189,6
10,22.1,Ascites,17022189,6
11,22.1,Cyanosis,17022189,6
12,22.1,Cholelithiasis,17022189,6
13,22.1,Asthenia,17022189,6
14,22.1,Breath sounds abnormal,17022189,6
15,22.1,Pulmonary mass,17022189,6
16,22.1,Chills,17022189,6
0,22.1,Diabetic ketoacidosis,17022215,6
1,22.1,Neutropenic sepsis,17022215,6
2,22.1,Atrial fibrillation,17022215,6
3,22.1,Type 2 diabetes mellitus,17022215,3
4,22.1,Blood glucose increased,17022215,6
5,22.1,Glycosylated haemoglobin increased,17022215,6
0,22.1,Arthritis,17022230,3
1,22.1,Gait inability,17022230,3
2,22.1,Fall,17022230,3
0,22.1,Vomiting,17022258,1
1,22.1,Malignant neoplasm progression,17022258,6
2,22.1,Decreased appetite,17022258,6
3,22.1,Nausea,17022258,1
0,22.1,Tendon rupture,17022259,4
0,22.1,Platelet count decreased,17022338,6
1,22.1,Recurrent cancer,17022338,6
2,22.1,Drug ineffective,17022338,6
0,22.1,Recurrent cancer,17022347,6
0,22.1,Recurrent cancer,17022348,6
0,22.1,Recurrent cancer,17022349,6
1,22.1,Drug ineffective,17022349,6
0,22.1,Drug ineffective,17022353,6
1,22.1,Recurrent cancer,17022353,6
0,22.1,Recurrent cancer,17022354,6
0,22.1,Recurrent cancer,17022355,6
1,22.1,Disease progression,17022355,6
2,22.1,Intentional product misuse,17022355,6
3,22.1,Drug ineffective,17022355,6
0,22.1,Cholangitis sclerosing,17022383,2
0,22.1,Death,17022392,5
0,22.1,Panniculitis,17022443,1
0,22.1,Panniculitis,17022444,1
1,22.1,Rash,17022444,6
2,22.1,Bursitis,17022444,1
0,22.1,Decreased appetite,17022495,2
0,22.1,Fatigue,17022597,1
1,22.1,Hypertension,17022597,1
2,22.1,Hypotension,17022597,1
3,22.1,Drug interaction,17022597,1
4,22.1,Bradycardia,17022597,1
0,22.1,Decreased appetite,17022599,3
1,22.1,Nausea,17022599,3
2,22.1,Neutropenia,17022599,3
0,22.1,Product dose omission,17022657,6
1,22.1,Upper respiratory tract infection,17022657,6
2,22.1,Pneumonia,17022657,6
0,22.1,Hypersensitivity,17022676,1
1,22.1,Hyperthermia,17022676,2
2,22.1,Tremor,17022676,1
3,22.1,Hypotension,17022676,2
0,22.1,Bicytopenia,17022699,1
0,22.1,Nephropathy toxic,17022707,6
1,22.1,Neutropenia,17022707,6
0,22.1,Rash,17022708,1
0,22.1,Off label use,17022713,
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,17022713,
2,22.1,Colorectal cancer metastatic,17022713,
0,22.1,Acute coronary syndrome,17022736,6
1,22.1,Acute myocardial infarction,17022736,6
0,22.1,Neutropenia,17022744,1
0,22.1,Intestinal perforation,17022755,1
0,22.1,Musculoskeletal pain,17022758,3
1,22.1,Pain in extremity,17022758,3
0,22.1,Prostate cancer,17022764,3
1,22.1,Terminal state,17022764,6
0,22.1,Malignant neoplasm progression,17022767,5
0,22.1,Death,17022770,5
0,22.1,Intentional product use issue,17022771,6
1,22.1,Device related infection,17022771,6
2,22.1,Ill-defined disorder,17022771,6
0,22.1,Polyuria,17022777,3
1,22.1,Dizziness,17022777,3
2,22.1,Fatigue,17022777,3
0,22.1,Death,17022779,5
0,22.1,Death,17022781,5
0,22.1,Pancreatitis,17022784,3
1,22.1,Death,17022784,5
2,22.1,Dermatitis acneiform,17022784,3
0,22.1,Death,17022792,5
0,22.1,Febrile neutropenia,17022797,6
1,22.1,Malignant neoplasm progression,17022797,6
2,22.1,Breast cancer metastatic,17022797,6
0,22.1,Blood glucose increased,17022805,6
1,22.1,Tension headache,17022805,1
2,22.1,Pulmonary embolism,17022805,1
3,22.1,Sepsis,17022805,6
4,22.1,Chest discomfort,17022805,1
5,22.1,Uterine infection,17022805,1
6,22.1,Bladder disorder,17022805,1
0,22.1,Syringe issue,17022806,
1,22.1,Intercepted product preparation error,17022806,
0,22.1,Terminal state,17022815,5
0,22.1,Limb discomfort,17022825,6
1,22.1,Electrocardiogram QT prolonged,17022825,6
2,22.1,Metastases to bone,17022825,6
3,22.1,Breast pain,17022825,6
4,22.1,Chest discomfort,17022825,6
0,22.1,Death,17022847,5
0,22.1,Liver disorder,17022862,1
0,22.1,Death,17022868,5
0,22.1,Hair disorder,17022934,6
1,22.1,Madarosis,17022934,3
2,22.1,Hair colour changes,17022934,6
3,22.1,Hair texture abnormal,17022934,6
4,22.1,Depression,17022934,6
5,22.1,Alopecia,17022934,3
0,22.1,Interstitial lung disease,17022947,5
0,22.1,Nausea,17022951,1
1,22.1,Vomiting,17022951,1
2,22.1,Dizziness,17022951,6
0,22.1,Liver disorder,17022981,6
0,22.1,Ischaemia,17022997,6
0,22.1,Diarrhoea,17023055,1
1,22.1,Colitis,17023055,1
2,22.1,White blood cell count decreased,17023055,1
3,22.1,Neutropenia,17023055,1
4,22.1,Hypomagnesaemia,17023055,1
5,22.1,Dyspnoea,17023055,1
0,22.1,Pneumonia,17023059,1
0,22.1,Interstitial lung disease,17023081,5
1,22.1,Pneumonia,17023081,5
0,22.1,Haemosiderosis,17023172,6
1,22.1,Cytomegalovirus test positive,17023172,6
2,22.1,Hepatitis,17023172,3
3,22.1,Pyrexia,17023172,6
4,22.1,Pneumocystis jirovecii pneumonia,17023172,6
5,22.1,Hepatic steatosis,17023172,6
0,22.1,Cardiac failure congestive,17023241,6
1,22.1,Malignant neoplasm progression,17023241,6
0,22.1,Hepatic failure,17023242,5
0,22.1,Toe amputation,17023243,6
1,22.1,Paronychia,17023243,3
0,22.1,Contusion,17023271,6
1,22.1,Joint swelling,17023271,2
2,22.1,Diarrhoea,17023271,2
3,22.1,Drug intolerance,17023271,6
4,22.1,Root canal infection,17023271,6
5,22.1,Malaise,17023271,6
6,22.1,Stomatitis,17023271,2
7,22.1,Peripheral swelling,17023271,2
0,22.1,Confusional state,17023272,3
1,22.1,Sleep disorder,17023272,3
0,22.1,Interstitial lung disease,17023280,5
1,22.1,Decreased appetite,17023280,6
2,22.1,Malignant neoplasm progression,17023280,6
0,22.1,Malignant neoplasm progression,17023290,6
1,22.1,Breast cancer female,17023290,6
0,22.1,Metastases to central nervous system,17023327,6
1,22.1,Cerebrovascular accident,17023327,6
0,22.1,Fatigue,17023365,3
1,22.1,Hypokalaemia,17023365,1
0,22.1,Acquired gene mutation,17023383,6
1,22.1,Metastases to liver,17023383,6
2,22.1,Drug resistance,17023383,6
3,22.1,Spinal pain,17023383,6
4,22.1,Brain neoplasm,17023383,6
5,22.1,Neck pain,17023383,3
0,22.1,Dry skin,17023421,3
1,22.1,Skin fissures,17023421,3
2,22.1,Dermatitis acneiform,17023421,2
0,22.1,Thrombosis,17023489,1
1,22.1,Glossodynia,17023489,1
2,22.1,Sleep disorder,17023489,3
3,22.1,Peripheral swelling,17023489,3
4,22.1,Fatigue,17023489,3
5,22.1,Alopecia,17023489,3
6,22.1,Cough,17023489,3
0,22.1,Hyperglycaemia,17023492,2
0,22.1,Death,17023509,5
0,22.1,Pulmonary tuberculosis,17023511,6
0,22.1,Malignant neoplasm progression,17023595,6
1,22.1,Anaemia,17023595,6
0,22.1,Mucosal inflammation,17023626,6
1,22.1,Nausea,17023626,6
2,22.1,Anaemia,17023626,6
3,22.1,Palmar-plantar erythrodysaesthesia syndrome,17023626,6
4,22.1,Neutropenia,17023626,6
5,22.1,Febrile neutropenia,17023626,6
0,22.1,Neoplasm progression,17023649,6
1,22.1,Diarrhoea,17023649,6
0,22.1,Cutaneous lupus erythematosus,17023651,1
0,22.1,Death,17023654,5
1,22.1,Intentional product use issue,17023654,6
0,22.1,Fatigue,17023698,6
1,22.1,Anaemia,17023698,6
2,22.1,Neuropathy peripheral,17023698,6
0,22.1,Drug resistance,17023746,6
1,22.1,Malignant neoplasm progression,17023746,6
0,22.1,Fall,17023752,6
1,22.1,Post procedural infection,17023752,1
2,22.1,Femur fracture,17023752,1
0,22.1,Necrosis,17023812,6
0,22.1,Metastases to central nervous system,17023816,6
1,22.1,Lung neoplasm,17023816,6
2,22.1,Disease progression,17023816,6
0,22.1,Diabetic ketoacidosis,17023818,6
1,22.1,Dermatitis psoriasiform,17023818,1
2,22.1,Inflammatory bowel disease,17023818,2
3,22.1,Fulminant type 1 diabetes mellitus,17023818,1
4,22.1,Autoimmune hepatitis,17023818,6
5,22.1,Gastroenteritis,17023818,6
0,22.1,Death,17023891,5
0,22.1,Rash erythematous,17023905,6
1,22.1,Skin toxicity,17023905,6
0,22.1,Gastrointestinal haemorrhage,17023946,6
1,22.1,Pulmonary embolism,17023946,6
2,22.1,Tumour pain,17023946,6
0,22.1,Ascites,17023960,6
1,22.1,Pleural effusion,17023960,6
2,22.1,Maternal exposure during pregnancy,17023960,6
3,22.1,Intentional product use issue,17023960,6
4,22.1,Adenocarcinoma gastric,17023960,5
5,22.1,Off label use,17023960,6
0,22.1,Encephalopathy,17023977,6
0,22.1,Hepatic failure,17023981,3
0,22.1,Neutropenia,17024045,6
1,22.1,Anaemia,17024045,6
2,22.1,Neoplasm progression,17024045,6
3,22.1,Nausea,17024045,6
4,22.1,Leukopenia,17024045,6
5,22.1,Asthenia,17024045,6
0,22.1,Coagulopathy,17024062,3
0,22.1,Syncope,17024064,2
1,22.1,Headache,17024064,2
2,22.1,Psychiatric symptom,17024064,2
3,22.1,Drug ineffective,17024064,6
4,22.1,Oropharyngeal pain,17024064,2
5,22.1,Gastritis erosive,17024064,2
6,22.1,Dyspnoea,17024064,2
0,22.1,Leukopenia,17024066,2
0,22.1,Rash,17024082,2
0,22.1,Diarrhoea,17024122,6
1,22.1,Nausea,17024122,6
2,22.1,Leukopenia,17024122,6
0,22.1,Stevens-Johnson syndrome,17024123,1
0,22.1,Cardiac failure chronic,17024181,5
1,22.1,General physical health deterioration,17024181,5
0,22.1,Product prescribing error,17024223,6
1,22.1,Depression,17024223,6
2,22.1,Drug interaction,17024223,6
0,22.1,Gait disturbance,17024232,1
1,22.1,Myalgia,17024232,1
0,22.1,Fall,17024239,4
1,22.1,Vertigo,17024239,4
2,22.1,Vomiting,17024239,4
0,22.1,Gastrointestinal toxicity,17024246,1
0,22.1,Diarrhoea,17024279,1
1,22.1,Abdominal pain upper,17024279,1
0,22.1,Fall,17024329,2
1,22.1,Syncope,17024329,2
0,22.1,Nausea,17024337,2
1,22.1,Decreased appetite,17024337,6
2,22.1,Vomiting,17024337,6
3,22.1,Small intestinal obstruction,17024337,6
4,22.1,Nausea,17024337,6
5,22.1,Fatigue,17024337,6
6,22.1,Vomiting,17024337,6
7,22.1,Dehydration,17024337,6
8,22.1,Urinary tract infection,17024337,6
0,22.1,Drug resistance,17024340,6
1,22.1,Malignant neoplasm progression,17024340,6
0,22.1,Dermatitis acneiform,17024377,6
1,22.1,Therapy partial responder,17024377,6
2,22.1,Metastases to lymph nodes,17024377,6
3,22.1,Metastases to gastrointestinal tract,17024377,6
4,22.1,Intestinal obstruction,17024377,6
5,22.1,Metastases to liver,17024377,6
6,22.1,Metastases to peritoneum,17024377,6
0,22.1,Dysmetria,17024405,3
1,22.1,Vertigo,17024405,3
2,22.1,Cerebellar syndrome,17024405,3
3,22.1,Gait disturbance,17024405,3
0,22.1,Disease progression,17024415,5
0,22.1,Malignant neoplasm progression,17024422,6
0,22.1,Prostate cancer,17024433,5
0,22.1,White blood cell count increased,17024507,1
1,22.1,Platelet count decreased,17024507,1
2,22.1,Pyrexia,17024507,2
3,22.1,Pneumonia aspiration,17024507,1
0,22.1,Visual impairment,17024508,6
1,22.1,Fall,17024508,6
2,22.1,Dementia Alzheimer^s type,17024508,6
3,22.1,Muscular weakness,17024508,6
4,22.1,Eye infection,17024508,6
5,22.1,Loss of consciousness,17024508,6
6,22.1,Asthenia,17024508,6
7,22.1,Drug ineffective,17024508,6
0,22.1,Asthenia,17024552,3
1,22.1,Ascites,17024552,3
2,22.1,Lung neoplasm malignant,17024552,5
0,22.1,Therapy non-responder,17024555,6
1,22.1,Malignant neoplasm progression,17024555,6
2,22.1,Metastases to liver,17024555,6
3,22.1,Dyspnoea,17024555,6
4,22.1,Polyneuropathy,17024555,6
5,22.1,Breast cancer metastatic,17024555,6
6,22.1,Pleural effusion,17024555,6
0,22.1,Product use in unapproved indication,17024578,6
1,22.1,Off label use,17024578,6
2,22.1,Death,17024578,5
0,22.1,Neutropenia,17024581,6
1,22.1,Stomatitis,17024581,6
2,22.1,Neuropathy peripheral,17024581,6
3,22.1,Thrombocytopenia,17024581,6
4,22.1,Vomiting,17024581,6
5,22.1,Nausea,17024581,6
6,22.1,Fatigue,17024581,6
7,22.1,Diarrhoea,17024581,6
8,22.1,Palmar-plantar erythrodysaesthesia syndrome,17024581,6
9,22.1,Anaemia,17024581,6
0,22.1,Skin toxicity,17024582,6
1,22.1,Neuropathy peripheral,17024582,6
2,22.1,Fatigue,17024582,6
3,22.1,Proteinuria,17024582,6
4,22.1,Nausea,17024582,6
5,22.1,Palmar-plantar erythrodysaesthesia syndrome,17024582,6
6,22.1,Lacrimation increased,17024582,6
7,22.1,Bone marrow toxicity,17024582,6
8,22.1,Diarrhoea,17024582,6
9,22.1,Mucosal inflammation,17024582,6
10,22.1,Anaphylactic reaction,17024582,6
0,22.1,Herpes zoster,17024587,3
0,22.1,Alopecia,17024616,2
1,22.1,Joint swelling,17024616,2
2,22.1,Arthralgia,17024616,2
0,22.1,Fatigue,17024618,3
0,22.1,Renal disorder,17024624,6
1,22.1,Bone marrow failure,17024624,6
2,22.1,Fatigue,17024624,6
0,22.1,Myositis,17024628,1
1,22.1,Cough,17024628,6
2,22.1,Chest pain,17024628,6
3,22.1,Dizziness,17024628,2
4,22.1,Headache,17024628,2
5,22.1,Nausea,17024628,2
6,22.1,Autoimmune arthritis,17024628,1
7,22.1,Death,17024628,5
8,22.1,Vomiting,17024628,2
9,22.1,General physical health deterioration,17024628,6
0,22.1,Drug resistance,17024727,6
1,22.1,Malignant neoplasm progression,17024727,6
